tiprankstipranks
Amicus Therapeutics (GB:0HF9)
LSE:0HF9

Amicus (0HF9) Cash flow

0 Followers

Amicus Cash Flow

GB:0HF9's free cash flow for Q4 2023 was $1.73M. For the 2023 fiscal year, GB:0HF9's free cash flow was decreased by $90.40M and operating cash flow was $3.46M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -69.09M$ -69.09M$ -167.65M$ -202.49M$ -233.29M$ -250.42M
Investing Cash Flow
$ 98.06M$ 98.06M$ 93.39M$ 78.76M$ -13.58M$ 95.15M
Financing Cash Flow
$ 61.68M$ 61.68M$ -7.47M$ 212.07M$ 262.86M$ 217.50M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 892.30M$ 250.08M$ 153.10M$ 249.43M$ 166.16M$ 146.34M
Income Tax Paid Supplemental Data
$ 8.53M$ 8.53M$ 1.61M$ 20.03M$ 10.37M$ 691.00K
Interest Paid Supplemental Data
$ 36.09M$ 36.09M$ 34.36M$ 30.47M$ 24.68M$ 16.97M
Issuance Of Capital Stock
----$ 0.00$ 188.99M
Issuance Of Debt
$ -20.96M$ -20.96M$ -283.00K$ -479.00K$ 385.93M$ 0.00
Repayment Of Debt
$ -408.32M$ -408.32M$ -283.00K$ -479.00K$ -155.32M$ -420.00K
Free Cash Flow
$ -76.53M$ -76.53M$ -166.93M$ -206.38M$ -236.52M$ -270.43M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Amicus Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis